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Fig. S1 Microtubule ring – DMSO treatment. Timeline of microtubule ring shrinkage dynamics over the 
course of 240s following activation. As in the no treatment condition, the ring structure of the microtubules 
is visible at early time points but looses definition as activation progresses. Scale bar 10 μm 
 
 
 
Fig. S2 Microtubule ring – Paclitaxel treatment. Timeline of microtubule ring shrinkage dynamics over the 
course of 240s following activation. In the paclitaxel-treated platelets, the microtubule ring structure is 
apparent at the early time points but as activation progresses it becomes harder to distinguish.  
Scale bar 10 μm 
 
 
 
Fig. S3 Microtubule ring – Vincristine treatment. Timeline of microtubule ring shrinkage dynamics over 
the course of 240s following activation. The vincristine-treated platelets showed a complete destruction of 
the microtubule ring structure. Scale bar 10 μm 
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Fig. S4 Actin Matrix – DMSO treatment. Timeline of actin matrix shrinkage dynamics over the course of 
240s following activation. DMSO-treated platelets started and ended with a smaller actin matrix than the no 
treatment platelets. Scale bar 10 μm 
 
 
 
Fig. S5 Actin Matrix – Latrunculin A. Timeline of actin matrix shrinkage dynamics over the course of 240s 
following activation.  The actin matrix of latrunculin A-treated platelets does not appear to go through any 
circumference changes as activation progresses. Scale bar 10 μm 
 
 
Fig. S6 Actin Matrix – Cytochalasin D. Timeline of actin matrix shrinkage dynamics over the course of 
240s following activation.  In cytochalasin D-treated platelets the actin matrix underwent all circumference 
changes within the first 40s, after which they reached a stable size. Scale bar 10 μm 
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